SPM 962
Sponsors
UCB Pharma, Otsuka Pharmaceutical Co., Ltd.
Conditions
Early Parkinson's DiseaseIdiopathic Restless Legs SyndromeParkinson Disease, IdiopathicParkinson's Disease
Phase 2
A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease Patients
CompletedNCT00537485
Start: 2007-09-30End: 2009-12-31Updated: 2014-03-19
A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients
CompletedNCT00666965
Start: 2008-06-30End: 2009-08-31Updated: 2014-04-25
A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome
CompletedNCT01562743
Start: 2008-08-31End: 2010-10-31Updated: 2014-04-23
A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients
CompletedNCT01628965
Start: 2008-01-31End: 2010-10-31Updated: 2014-03-19
A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients
CompletedNCT01628848
Start: 2006-08-31End: 2008-04-30Updated: 2014-03-19
A Long-Term Extension Trial From Late Phase II of SPM 962 in Advanced Parkinson's Disease Patients
CompletedNCT01631812
Start: 2006-12-31End: 2010-02-28Updated: 2014-03-19
A Dose-ranging Study for SPM 962 in Parkinson's Disease Patients
CompletedNCT01634243
Start: 2005-01-31End: 2006-05-31Updated: 2014-03-19
Phase 3
A Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's Disease
CompletedNCT00243971
Start: 2004-11-30End: 2005-10-31Updated: 2014-09-25
Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa
CompletedNCT00244387
Start: 2004-03-31End: 2005-07-31Updated: 2014-09-25
Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)
CompletedNCT01084551
Start: 2010-02-28End: 2011-09-30Updated: 2014-06-05
A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients
CompletedNCT01628926
Start: 2009-06-30End: 2011-05-31Updated: 2014-05-23
A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients
CompletedNCT01631825
Start: 2009-10-31End: 2012-06-30Updated: 2014-03-19